Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673974 | SCV000799238 | likely pathogenic | Nephropathic cystinosis | 2018-05-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003768007 | SCV004573523 | likely pathogenic | Ocular cystinosis; Juvenile nephropathic cystinosis; Inborn genetic diseases | 2023-04-09 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Studies have shown that disruption of this splice site is associated with altered splicing resulting in multiple RNA products (PMID: 12442267). ClinVar contains an entry for this variant (Variation ID: 557791). A splice variant(s) at this position has also been reported as 1192-2A>G. Disruption of this splice site has been observed in individual(s) with cystinosis (PMID: 12442267, 28793998, 29421779). This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 10 of the CTNS gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CTNS are known to be pathogenic (PMID: 9537412, 27102039). |